SHANA KLOSKE: Open Payments
NPI 1629678768 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,290 in 162 payments from 27 companies in 2025. Trend: 2023 $3,072 · 2024 $3,381 · 2025 $3,290
Food & beverage: $3,290
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $638 |
| TG Therapeutics, Inc. | 11 | $413 |
| UCB, Inc. | 8 | $290 |
| Novartis Pharmaceuticals Corporation | 15 | $285 |
| Amgen Inc. | 12 | $203 |
| Biogen, Inc. | 8 | $194 |
| PFIZER INC. | 12 | $156 |
| Amneal Pharmaceuticals LLC | 13 | $147 |
| EMD Serono, Inc. | 5 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $93 |
Products named: BRIUMVI, Rystiggo, KESIMPTA, UBRELVY, QULIPTA, CREXONT, UPLIZNA, BOTOX.
Industry payments across AR — which companies pay providers there.
